Sponsor:
Retina Research Institute, LLC
Code:
NCT07895420
Conditions
No Condition
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
chloroprocaine HCL 3%
Subconjunctival Lidocaine
Brief summary:
Conditions
No Condition
Study ID
NCT07895420
Start date
Oct 30, 2025
Status verified date
Sep, 2026
Completion date
Dec 30, 2026
Anticipated
Primary completion date
Dec 30, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
80 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
active comparator: Iheezo
active comparator: Subconjunctival Lidocaine
Interventions
chloroprocaine HCL 3%
Subconjunctival Lidocaine
Primary outcome measure
Central contacts
Locations
The Retina Institute
Recruiting
Glen Carbon, Illinois, United States, 62034
Contacts
The Retina Institute
Recruiting
Chesterfield, Missouri, United States, 63017
Contacts
The Retina Institute
Recruiting
City of Saint Peters, Missouri, United States, 63376
Contacts
The Retina Institute
Recruiting
St Louis, Missouri, United States, 63128
Contacts
Sponsor
Retina Research Institute, LLC
Last update posted
Oct 26, 2026
Last verified
Sep, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-27. This information was provided to ClinicalTrials.gov by Retina Research Institute, LLC on 2026-10-26. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.